Article ID Journal Published Year Pages File Type
5596879 The Annals of Thoracic Surgery 2017 8 Pages PDF
Abstract
High expression of CD44 and CD90 was associated with significantly reduced relapse-free survival in NSCLC patients. These results suggest that CD44 and CD90 may be important markers of tumor progression in NSCLC.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , ,